Latest News and Press Releases

CytoSorbents Strengthens Balance Sheet with Additional $1.6M in Aggregate Gross Proceeds from Shareholder Exercise of Series A Right Warrant

SINGAPORE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group has filed its Prospectus...

CytoSorbents Strengthens Balance Sheet by $11.25M in Unrestricted Cash through Oversubscribed Shareholder Rights Offering and Satisfied Debt Covenant

CytoSorbents' Preliminary Unaudited Q4 2024 Product Revenue Increased 22-25% From A Year Ago With Product Gross Margins Of ~70%

CytoSorbents Rights Offering Begins. Eligible Stockholders are Being Distributed a Dividend of Subscription Rights Based on Shares of CTSO Held.

CytoSorbents Is Scheduling In-Person Investor Meetings During the JP Morgan Healthcare Conference from Jan 13-15, 2025 in San Francisco.

CytoSorbents Announces Rights Offering Exclusive to Stockholders Who Hold or Have Bought CTSO Common Stock by Market Close on Friday, December 13, 2024

The Western Investment Company of Canada Limited (TSXV: WI) has closed its previously announced rights offering for aggregate gross proceeds of $6,296,946.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATES CALGARY, Alberta, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Pieridae Energy Limited (“Pieridae” or the “Company”)...

Gross fundraising of approximately €8 million or 100% of the planned rights offering as proposed and announced on 30 April 2024 Allows to continue the clinical and regulatory development of ZEPIZURE®...